Pre-Clinical CRO

Pre-Clinical CRO
Product Description

- Transient protein production CHO (& HEK) from proprietary QMCF expression platform - Hundreds of protein candidates in parallel - From mgs to grams, from ml’s to dozens of liters scale (chemically defined, serum-free medium) - Protein for in-vitro and in-vivo purposes - Automated, high-throughput platform purifications till in-depth multi-step downstream processes - Latest & broad analytical capabilities, incl. high-throughput platforms: Biochemical, biophysical & cell-based potency assays - ADCC enhancement platform, for afucosylated mAbs - Pre-clinical ADC capabilities, expression, conjugation, purification, analytics - The goal is to analyze candidate molecules for their critical characteristics (manufacturability, stability, activity, potency), to select a few lead candidates, further optimize them as needed and proceed straight into clinical development, without any CRO to CDMO tech transfer

Read more Show less

Icosagen

  • Country/Region:
    Estonia
  • On CPHI since:
    2024
  • Certificates:
    2
  • Employees:
    100 - 249
Company types
Biopharmaceutical company
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
View company profile

Icosagen

  • Country/Region:
    Estonia
  • On CPHI since:
    2024
  • Certificates:
    2
  • Employees:
    100 - 249
Company types
Biopharmaceutical company
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
View company profile

More Products from Icosagen (4)

  • Clinical CDMO

    Product Clinical CDMO

    - Under one single roof together with discovery and pre-clinical CRO departments, capitalizing on the previously in-house gained molecule know-how, intact project teams and existing legal agreements - Stable, proprietary IcoCell® CHO cell line development platform with competitive titers & timelines, fee-...
  • Antibody DISCOVERY

    Product Antibody DISCOVERY

    - Antigen protein production in HEK & CHO - Antibody discovery in chicken, rabbits, alpaca VVH’s and by Phage Display in vitro - Functional antibody discovery against integral multi-pass transmembrane protein (such as transporters, GPCRs, & ion channels) by proprietary pseudotyped VLP-based display techn...
  • CRDMO Concept & Benefit

    Product CRDMO Concept & Benefit

    - When teaming up with Icosagen, you combine forces with a single expert team at one single site - To navigate your protein project together, from antibody discovery over transient R&D milligrams to stable IcoCell® CHO cell line development clinical GMP kilograms - One team, one site, your project - Sav...
  • Icosagen as Technology & Service Provider

    Product Icosagen as Technology & Service Provider

    - Mammalian protein drug candidate CRDMO - Uniquely combining pre-clinical CRO and clinical CDMO capabilities - 230+ people, >200 scientists (>45 PhD’s) all in one single site - Founded 1999, fully independent, successful 26-yr family-business - Integrated, modular CRDMO services, from discovery to 100...